Behind the Bell: Autonomix Medical, Inc.

In this episode of Behind the Bell, Lori Bisson, Autonomix Medical, Inc. CEO, shares how Nasdaq helped her company through the process of going public. Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated.

Transcript: 

You need to surround yourself with people that are passionate, that will take risks with you and that you love going to work with day in and day out.

It makes work a joy instead of a job. Autonomix is tackling a very important segment in the healthcare space.

We are going after electrophysiology, which is the use of electricity in medical devices. Our recent IPO closed with over 3,500 shareholders that believed in our vision enough to invest alongside the work we're doing.

And so that’s validation from the investing community, and listing on Nasdaq is clear validation from the financial community.

It's been a really fun process to go through the listing process and to work with them.

Nasdaq does its core job of being an exchange really well, but they also walk alongside smaller companies with offerings like ESG support or board portals that help being a public company easier when you're a small-cap company.